<--- Back to Details
First PageDocument Content
Lysosomal storage diseases / Orphan drugs / Glycogen storage disease type II / Hepatology / Alglucosidase alfa / Pharmaceutical Benefits Scheme / Amyotrophic lateral sclerosis / Clinical trial / Health / Medicine / Rare diseases
Date: 2014-10-01 21:56:22
Lysosomal storage diseases
Orphan drugs
Glycogen storage disease type II
Hepatology
Alglucosidase alfa
Pharmaceutical Benefits Scheme
Amyotrophic lateral sclerosis
Clinical trial
Health
Medicine
Rare diseases

Add to Reading List

Source URL: www.pbs.gov.au

Download Document from Source Website

File Size: 32,91 KB

Share Document on Facebook

Similar Documents

Medicare Australia / Medical privacy / Health / Medicare card / Medicare / Electronic health record / Pharmaceutical Benefits Scheme / United States National Health Care Act / Personally Controlled Electronic Health Record

My Health Record system Application to register for a My Health Record Purpose of this form

DocID: 1q840 - View Document

Healthcare quality / Health care / Health / Medical terminology / Pharmaceutical sciences / Pharmaceuticals policy / Medicare Australia / Pharmaceutical Benefits Scheme / Compliance / Antimicrobial stewardship / Antidepressant

Key findings and recommendations

DocID: 1q0IM - View Document

Medicare Australia / Medicare / Electronic health record / Pharmaceutical Benefits Scheme / Health care in Australia

DOHA_stacked_eHealth_inline

DocID: 1oMB9 - View Document

Medicinal chemistry / Pharmacy / Patient safety / Health informatics / Pharmaceutical Benefits Scheme

Save On Health Care   

DocID: 1ndVH - View Document

Health / Pharmaceutical industry / Prescription medication / Generic drug / Food and Drug Administration / Pharmacy / Pharmaceutical drug / Pharmaceutical Benefits Scheme / Pharmaceutical policy / Pharmaceutical sciences / Pharmacology / Pharmaceuticals policy

April 21, 2015 The Honorable Rob Bonta Chair, Assembly Health Committee State Capitol, Room 6005 Sacramento, CARe: SUPPORT the Pharmaceutical Cost Transparency Act ofAB 463)

DocID: 19Z75 - View Document